Black Diamond Therapeutics, Inc. Common Stock — Rendiconto Finanziario Trimestrale (NASDAQ:BDTX) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Market Capitalization 164.42 M
Employee 21
Founded 2014
CEO N/A
Website www.blackdiamondtherapeutics.com
Headquarter Massachusetts, United States
FIGI BBG00MS4Y0W9
Industry Technology

Ricavi totali

Utile netto

Utile base per azione (EPS base)

Debito totale

Liquidità libera

Disponibilità liquide e mezzi equivalenti

164.42 M Capitalizzazione di mercato

Rapporto prezzo/utili

6.23

Rapporto prezzo/fatturato

2

Notizie

Why Is Black Diamond (BDTX) Up 19.3% Since Last Earnings Report?

BDTX and Brain Metastases: Why CNS Activity Could Matter in 2026

Black Diamond Stock: Weighing Catalysts vs. Concentration

BDTX: What Silevertinib Data Say About EGFR NSCLC Upside

Black Diamond Therapeutics: Market Yawning About Data, But I See Opportunity (BDTX)

DAWN Stock Jumps 66% on $2.5B Buyout Offer From Servier

Is Black Diamond Therapeutics (BDTX) Stock Outpacing Its Medical Peers This Year?

What Makes Black Diamond (BDTX) a New Strong Buy Stock

New Strong Buy Stocks for January 9th

Down 30.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Black Diamond (BDTX)

Stifel conferma il rating Buy su Black Diamond Therapeutics con target a $8

Stifel reiterates Buy rating on Black Diamond Therapeutics stock at $8